Gelonghui, April 10 | According to the Stock Exchange's latest equity disclosure data, on April 8, 2024, Yuanda Pharmaceutical (00512.HK) was granted an increase of 101,000 shares by Executive Director Zhou Chao at an average price of HK$3955 per share on the market, involving approximately HK$39,500.
After increasing his holdings, Zhou Chao's latest shareholding was 263,000 shares.